Rüdiger Trojok

Rüdiger Trojok, a Dipl. biologist, is co-founder and Managing Director of Medea Biopharma GmbH, a German biotech start-up. He is specialized in developing a new generation of sustainable, precise, and effective bacteriophage based antimicrobial drugs as alternatives to antibiotics. Before, he was working as a consultant to the German Parliament on synthetic Biology and Phage Therapy and made station at KIT and TUM. There, as director of the Molecular Venture Labs at TUM, he developed and built a novel Covid-19 rapid test training and production facility for Ghana.